Emergent BioSolutions | EBS - Zapasy





Zapasy Zmiana Data
Acadia Pharmaceuticals USD 108.67M 77.1M 2026-06
Akebia Therapeutics USD 13.02M 22K 2026-06
ALKERMES USD 298.96M 37.75M 2026-06
Alnylam Pharmaceuticals USD 97.11M 103.04M 2026-06
Amarin USD 164.07M 19.51M 2026-06
ANI Pharmaceuticals USD 143.15M 319K 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Coherus Biosciences USD 5.67M 842K 2026-06
Emergent BioSolutions USD 328.9M 25.2M 2023-12
Exelixis USD 28.73M 2.12M 2026-06
Glaxosmithkline GBP 6.16B 39M 2026-03
Heron Therapeutics USD 54.57M 2.33M 2022-12
Ionis Pharmaceuticals USD 50.83M 45.28M 2026-06
Lexicon Pharmaceuticals USD 276K 5K 2026-03
Lonza CHF 1.68B 163M 2025-12
Merck USD 6.21B 272M 2026-06
Moderna USD 280M 134M 2026-06
Myriad Genetics USD 30.6M 2.7M 2026-06
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 104.2M 39.7M 2026-06
Pacira USD 134.57M 15.8M 2026-06
Pfizer USD 9.94B 722M 2026-06
PTC Therapeutics USD 91.35M 15.79M 2026-06
Sanofi EUR 24.12B 620M 2026-06
Sarepta Therapeutics USD 904.27M 96.84M 2026-06
United Therapeutics USD 193.8M 15.5M 2026-06
Vanda Pharmaceuticals USD 1.85M 190K 2025-12